Try our business solution for free!

Total assets of BioNTech 2017-2021

Published by
Matej Mikulic,
Apr 4, 2022
On November 9th 2020, German biotech company BioNTech in cooperation with U.S. pharma giant Pfizer were the first to announce a proven COVID-19 vaccine to be ready for mass production by year-end. In 2021, total assets of biotech company BioNTech SE stood at some 15.8 billion U.S. dollars, a significant increase from around 2.3 billion dollars in 2020. This statistic illustrates the total assets of BioNTech SE from 2017 to 2021.

Total assets of BioNTech SE from 2017 to 2021 (in million euros)

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2022

Region

Worldwide

Survey time period

2017 to 2021

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Coronavirus: the pharma and medtech response "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statistics on Coronavirus: the pharma and medtech response

Pharma - before the pandemic

6

Treatments and vaccines

8

Focus: BioNTech and Moderna

7

Opinions on COVID-19 vaccines

6

Business impact

4

Medtech - before the pandemic

5

Ventilators and testing

7

Further related statistics

13

Further Content: You might find this interesting as well

Statistics

Topics

BioNTechBiotech drugsmRNA technologyCoronavirus disease (COVID-19) pandemicCoronavirus (COVID-19) in the U.S.
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu